Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Cadus/Solvay yeast-based drug discovery program receives boost from EC

May 3, 1996

Drug discovery agreement reached by CombiChem and Teijin

May 3, 1996

Anaderm Research formed to develop skin and hair therapeutics

May 3, 1996

Sunrise Technologies will expand phase II LTK trials

April 26, 1996

VIMRx acquires rights to compounds based on RILON technology

April 26, 1996

SKB receives rights to OraSolve dosage technology from CIMA

April 26, 1996

Oxford Molecular, Yamanouchi to codevelop ion channel modulators

April 26, 1996

RMP-7 advances to phase I/II in Europe

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...